Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1423053 MIAMI, FL
Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$2,483,539
+$2,483,539 QoQ
Shares Held
73,304
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#251
of 675 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Jun 30, 2026
CallValue
$95,609,360
CallShares
2,822,000
PutValue
$45,656,688
PutShares
1,347,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,675,844 across 65 Drug Manufacturers - Specialty & Generic names. TEVA ranks #26 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 9,668,611 $237,944,516
2 ZTS
Zoetis Inc.
 3,188,263 $229,108,578
3 UTHR
UNITED THERAPEUTICS Corp
 304,692 $165,091,266
4 LNTH
Lantheus Holdings, Inc.
 1,376,480 $152,706,691
5 INDV
Indivior Pharmaceuticals, Inc.
 2,667,827 $109,460,941
6 ALKS
Alkermes plc.
 1,645,101 $86,203,291
7 SUPN
Supernus Pharmaceuticals, Inc.
 1,373,982 $63,903,902
8 HIMS
Hims & Hers Health, Inc.
 846,936 $29,363,271

All Filings in TEVA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,483,539 73,304
2026-06-30 $45,656,688 1,347,600
2026-06-30 $95,609,360 2,822,000
2026-03-31 $58,203,888 1,932,400
2026-03-31 $38,418,060 1,275,500
2025-12-31 $77,678,569 2,488,900
2025-12-31 $54,739,219 1,753,900
2025-12-31 $120,091,553 3,847,855
2025-09-30 $30,584,820 1,514,100
2025-09-30 $43,797,640 2,168,200
2025-09-30 $24,929,931 1,234,155
2025-06-30 $44,077,124 2,629,900
2025-06-30 $37,091,321 2,213,086
2025-06-30 $21,759,508 1,298,300
2025-03-31 $17,389,618 1,131,400
2025-03-31 $52,865,115 3,439,500
2025-03-31 $43,852,008 2,853,091
2024-12-31 $86,273,376 3,914,400
2024-12-31 $95,331,816 4,325,400
2024-12-31 $52,574,700 2,385,422
2024-09-30 $9,462,302 525,100
2024-09-30 $41,611,784 2,309,200
2024-09-30 $62,501,685 3,468,462
2024-06-30 $9,581,000 589,600
2024-06-30 $28,736,711 1,768,413
2024-06-30 $64,296,375 3,956,700
2024-03-31 $72,103,877 5,110,126
2024-03-31 $24,921,082 1,766,200
2024-03-31 $20,366,374 1,443,400
2023-12-31 $10,305,324 987,100
2023-12-31 $11,504,880 1,102,000
2023-12-31 $121,141,197 11,603,563
2023-09-30 $11,702,460 1,147,300
2023-09-30 $30,911,599 3,030,549
2023-09-30 $16,261,860 1,594,300
2023-06-30 $7,556,355 1,003,500
2023-06-30 $33,779,918 4,486,045
2023-06-30 $13,739,238 1,824,600
2023-03-31 $5,394,075 609,500
2023-03-31 $84,529,456 9,551,351
2023-03-31 $20,113,395 2,272,700
2022-12-31 $24,364,736 2,671,572
2022-12-31 $37,597,200 4,122,500
2022-12-31 $19,846,944 2,176,200
2022-09-30 $20,262,156 2,510,800
2022-09-30 $28,999,545 3,593,500
2022-09-30 $20,390,928 2,526,757
2022-06-30 $33,899,408 4,507,900
2022-06-30 $72,542,965 9,646,671
2022-06-30 $39,213,792 5,214,600